The pharmaceutical giant's stock has tumbled over the past year and a half, but it could be poised to storm back.

Since early August, the world’s most valuable pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), has put on a stellar ...

A new study uses shopping receipts to show how appetite changes from Ozempic and Wegovy affect grocery and restaurant ...

As Novo Nordisk’s weight-loss pill Wegovy (semaglutide) readies for a launch in the United States early January, it will be a ...

Someone is having a very happy holiday season after a ticket sold in Arkansas won the massive $1.817 billion Powerball prize. Powerball officials announced on Christmas Day that a single ticket sold ...

Researchers will test the drugs against the disease after finding prostate cancer cells were more likely to duplicate and ...

Hyderabad: Global pharma heavyweights Eli Lilly and Novo Nordisk are racing to lock in market leadership in India’s blooming ...

THREE women from one family lost a combined weight of over 20st after turning to fat-busting jabs three years ago – and now they want to help others achieve their dream body. Debbie ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The U.S. Food and Drug Administration’s ...

The drugs' high prices, along with spotty insurance coverage, have left them out of reach for many Americans. Read more at ...

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

Wegovy is one of the new wave medications that in recent years have had a huge impact on people looking to l ose weight.